Presenter Information

Michael Everett Probasco

Department

Chemical and Biochemical Engineering

Major

Chemical Engineering

Research Advisor

Henthorn, David

Advisor's Department

Chemical and Biochemical Engineering

Funding Source

Chemical & Biological Engineering

Abstract

Poly (lactic acid-co-glycolic acid) (PLAGA) is a commonly used polymer carrier in the controlled delivery of therapeutic agents because it degrades into naturally occurring compounds which the body easily metabolizes over a period of time. The goal of the research is to develop microparticles loaded with a drug of choice, in this case BEstradiol, establish predictable time degradation of the drug in the body, and to be able to develop a process method that results in consistent production.

Biography

Michael Probasco, also known as Everett (his middle name), was born in Montgomery, Alabama to Michael and Denise Probasco. Everett's father was in the military and has traveled to more than 20 different countries. After his father's retirement, he went to high school at Francis Howell North in St. Charles, Missouri where he was in the marching band for four years and was the drum major for one. Everett has attending Missouri S& T since the fall of 2004 and is very active in school organizations, · these include, KMNR college radio, Air Force ROTC, Kappa Sigma Fraternity, Military Aerospace Society, and Blue Sabers Doll Team & Color Guard, all of which he currently holds or has held a position in. Upon graduation in December of 2008, he will commission into the Air Force and begin pilot training.

Research Category

Engineering

Presentation Type

Poster Presentation

Document Type

Poster

Location

Havener Center, Upper Atrium/Hallway

Presentation Date

9 April 2008, 9:00 am - 11:45 am

Share

COinS
 
Apr 9th, 8:00 AM Apr 9th, 5:00 PM

The Synthesis of Biodegradable Microparticles for Pharmaceutical Use

Havener Center, Upper Atrium/Hallway

Poly (lactic acid-co-glycolic acid) (PLAGA) is a commonly used polymer carrier in the controlled delivery of therapeutic agents because it degrades into naturally occurring compounds which the body easily metabolizes over a period of time. The goal of the research is to develop microparticles loaded with a drug of choice, in this case BEstradiol, establish predictable time degradation of the drug in the body, and to be able to develop a process method that results in consistent production.